Skip to main content

Table 1 General profile of phenotypic drug susceptibility testing profile per year

From: Tuberculosis drug resistance in Bamako, Mali, from 2006 to 2014

Phenotypic drug susceptibility testing profile 2006 2007 2008 2009 2010 2011 2012 2013 2014 Total
Total number of isolates tested 18 53 33 15 10 29 53 87 39 337
Pan susceptible 18 37 22 2 1 16 34 63 17 210
S 0 1 3 0 0 0 2 8 2 16
I 0 0 1 1 0 2 4 2 2 12
R 0 1 0 0 0 0 0 0 1 2
E 0 0 0 0 0 0 1 0 0 1
S, I 0 1 2 2 0 0 1 5 5 16
S, I, E 0 1 0 0 0 0 1 1 0 3
S, R 0 0 0 0 0 0 0 0 1 1
S, R, E 0 0 0 0 0 0 0 0 1 1
S, I, R 0 2 0 0 2 0 0 0 1 5
I, R, E 0 2 1 1 0 1 0 0 0 5
I, R 0 1 1 0 0 3 1 0 4 10
S, I, R, E 0 7 3 9 7 7 9 8 5 55
Total # of MDR-TB per Year 0 12 5 10 9 11 10 8 10 75
% of MDR-TB per Year 0.00 22.6 15.2 66.7 90.0 37.9 18.9 9.2 25.6 22.3
  1. S streptomycin, I isoniazid, R rifampicin, E ethambutol, MDR-TB multidrug resistance (resistance to at least isoniazid and rifampicin)